Cognex Corp (CGNX) Tops Q3 EPS by 9c
Tweet
Share
E-mailGet Alerts CGNX Hot Sheet
Price: $62.58 +0.53%
Revenue Growth %: +13.1%
Financial Fact:
Total cost of revenue: 32.75M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +13.1%
Financial Fact:
Total cost of revenue: 32.75M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Cognex Corp (NASDAQ: CGNX) reported Q3 EPS of $0.21, $0.09 better than the analyst estimate of $0.12. Revenue for the quarter came in at $209.62 million versus the consensus estimate of $194.55 million.
GUIDANCE:
Cognex Corp sees Q4 2022 revenue of $235-255 million, versus the consensus of $226 million.
For earnings history and earnings-related data on Cognex Corp (CGNX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
- Morgan Stanley upgrades Synopsys as it turns selective on chip stocks
- Ambarella (AMBA) Tops Q2 EPS by 1c; offers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
